BeyondSpring Inc. Repayments of Related Party Debt
BeyondSpring Inc. (BYSI) reported Repayments of Related Party Debt of $0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2023-04-18
- BeyondSpring Inc. repayments of related party debt for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- BeyondSpring Inc. repayments of related party debt for the quarter ending 2020-12-31 was $3.00K, a 99.88% decline year-over-year.
- BeyondSpring Inc. repayments of related party debt for the quarter ending 2019-12-31 was $2.54M.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 20-F · filed 2023-04-18 | ||
| 2021-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $0.00 20-F · filed 2023-04-18 | |
| 2021-09-30 | $0.00 6-K · filed 2021-12-30 | ||
| 2020-12-31 | $3.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $64.00K 20-F · filed 2023-04-18 | |
| 2020-09-30 | $61.00K 6-K · filed 2021-12-30 | ||
| 2019-12-31 | $2.54M derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $5.87M 20-F · filed 2022-04-14 | |
| 2019-09-30 | $3.33M 6-K · filed 2020-11-17 | ||
| 2015-12-31 | $402.00K 20-F · filed 2018-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |